A Phase II Study of Fixed-Dose Rate Gemcitabine Plus Low-Dose Cisplatin Followed by Consolidative Chemoradiation for Locally Advanced Pancreatic Cancer
- 1 July 2007
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 68 (3), 809-816
- https://doi.org/10.1016/j.ijrobp.2007.01.005
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Phase II Study of Fixed Dose Rate Gemcitabine With Cisplatin for Metastatic Adenocarcinoma of the PancreasJournal of Clinical Oncology, 2006
- The current role of staging laparoscopy for adenocarcinoma of the pancreas: a reviewAnnals Of Oncology, 2005
- Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III TrialJournal of Clinical Oncology, 2005
- Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma?Journal of Gastrointestinal Surgery, 2004
- Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Randomized Phase II Comparison of Dose-Intense Gemcitabine: Thirty-Minute Infusion and Fixed Dose Rate Infusion in Patients With Pancreatic AdenocarcinomaJournal of Clinical Oncology, 2003
- Laparoscopy and peritoneal cytology in the staging of pancreatic cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1JNCI Journal of the National Cancer Institute, 1988
- Radiation therapy for pancreatic cancer: Eleven year experience at the JCRTInternational Journal of Radiation Oncology*Biology*Physics, 1985